Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines

被引：0

作者：

Lukas Donix

Holger H. H. Erb

Claudia Peitzsch

Anna Dubrovska

Manuel Pfeifer

Christian Thomas

Susanne Fuessel

Kati Erdmann

机构：

[1] Technische Universität Dresden,Department of Urology, Faculty of Medicine

[2] National Center for Tumor Diseases (NCT),National Center for Radiation Research in Oncology (OncoRay), Faculty of Medicine

[3] Dresden,Helmholtz

[4] Germany: German Cancer Research Center (DKFZ),Zentrum Dresden

[5] Heidelberg,Rossendorf

[6] Germany; Faculty of Medicine and University Hospital Carl Gustav Carus,Institute of Legal Medicine, Faculty of Medicine

[7] Technische Universität Dresden,undefined

[8] Dresden,undefined

[9] Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR),undefined

[10] Technische Universität Dresden,undefined

[11] Institute of Radiooncology - OncoRay,undefined

[12] German Cancer Consortium (DKTK),undefined

[13] Partner Site Dresden,undefined

[14] Dresden and German Cancer Research Center (DKFZ),undefined

[15] Technische Universität Dresden,undefined

来源：

Journal of Cancer Research and Clinical Oncology | 2022年 / 148卷

关键词：

Cisplatin; Docetaxel; mCRPC; NEPC; Prostate cancer; Radiotherapy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1313 / 1324

页数：11

共 50 条

[41] Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles
Iwasaki, I
Sugiyama, H
Kanazawa, S
Hemmi, H
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 49 (06) : 438 - 444
[42] STUDIES ON CROSS-RESISTANCE PATTERNS AND CHROMOSOME CHANGES IN CISPLATIN-RESISTANT HUMAN BLADDER AND TESTICULAR CELL-LINES
WALKER, MC
PARRINGTON, JM
WEST, LF
MASTERS, JRW
BRITISH JOURNAL OF CANCER, 1989, 60 (03) : 497 - 498
[43] Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles
Iwao Iwasaki
Hisahiko Sugiyama
Shinsaku Kanazawa
Hiromichi Hemmi
Cancer Chemotherapy and Pharmacology, 2002, 50 : 341 - 341
[44] Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles
Iwao Iwasaki
Hisahiko Sugiyama
Shinsaku Kanazawa
Hiromichi Hemmi
Cancer Chemotherapy and Pharmacology, 2002, 49 : 438 - 444
[45] Increased DT-diaphorase expression and cross-resistance to mitomycin C in a series of cisplatin-resistant human ovarian cancer cell lines
ODwyer, PJ
Perez, RP
Yao, KS
Godwin, AK
Hamilton, TC
BIOCHEMICAL PHARMACOLOGY, 1996, 52 (01) : 21 - 27
[46] RESISTANCE TO CISPLATINUM AND PATTERNS OF CROSS-RESISTANCE IN 2 AUTOLOGOUS HUMAN OVARIAN ADENOCARCINOMA CELL-LINES
HAYWARD, IP
LAWRIE, SS
LAUDONIO, ARR
MCDONALD, A
SMYTH, JF
BRITISH JOURNAL OF CANCER, 1986, 54 (01) : 185 - 185
[47] Cross-resistance, cisplatin accumulation, and platinum-DNA adduct formation and removal in cisplatin-sensitive and -resistant human hepatoma cell lines
Johnson, SW
Shen, DW
Pastan, I
Gottesman, MM
Hamilton, TC
EXPERIMENTAL CELL RESEARCH, 1996, 226 (01) : 133 - 139
[48] Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines
Radosław Januchowski
Karolina Sterzyńska
Katarzyna Zaorska
Patrycja Sosińska
Andrzej Klejewski
Maciej Brązert
Michał Nowicki
Maciej Zabel
Journal of Ovarian Research, 9
[49] Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines
Januchowski, Radoslaw
Sterzynska, Karolina
Zaorska, Katarzyna
Sosinska, Patrycja
Klejewski, Andrzej
Brazert, Maciej
Nowicki, Michal
Zabel, Maciej
JOURNAL OF OVARIAN RESEARCH, 2016, 9 : 1 - 11
[50] Lipid Mediated Heterogeneity in Cisplatin Resistance in Cancer Cell Lines
Raghunathan, Krishnan
Ahsan, Aarif
Ray, Dipankar
Nyati, Mukesh
Veatch, Sarah
BIOPHYSICAL JOURNAL, 2014, 106 (02) : 41A - 41A

← 1 2 3 4 5 →